Safety and efficacy of the immunosuppressive agent 6-tioguanine in murine model of acute and chronic colitis
<p>Abstract</p> <p>Background</p> <p>Oral thiopurines are effective and widely used in treatment of inflammatory bowel disease (IBD) in humans, although their use is limited due the development of adverse events. Here, we examine the efficacy and toxicity of oral treatm...
Main Authors: | van Bodegraven Adriaan A, Vos Rene M, de Boer Nanne K, Jharap Bindia, Klimesova Klara, Tlaskalova-Hogenova Helena, Rossmann Pavel, Kverka Miloslav, Lukas Milan, Mulder Chris J |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-05-01
|
Series: | BMC Gastroenterology |
Online Access: | http://www.biomedcentral.com/1471-230X/11/47 |
Similar Items
-
Lysate of probiotic Lactobacillus casei DN-114 001 ameliorates colitis by strengthening the gut barrier function and changing the gut microenvironment.
by: Zuzana Zakostelska, et al.
Published: (2011-01-01) -
Diet Rich in Animal Protein Promotes Pro-inflammatory Macrophage Response and Exacerbates Colitis in Mice
by: Klara Kostovcikova, et al.
Published: (2019-04-01) -
Oral Bacterial and Fungal Microbiome Impacts Colorectal Carcinogenesis
by: Klara Klimesova, et al.
Published: (2018-04-01) -
Patterns of early gut colonization shape future immune responses of the host.
by: Camilla Hartmann Friis Hansen, et al.
Published: (2012-01-01) -
Urinary Intestinal Fatty Acid-Binding Protein Can Distinguish Necrotizing Enterocolitis from Sepsis in Early Stage of the Disease
by: Stepan Coufal, et al.
Published: (2016-01-01)